<HashMap><database>biostudies-literature</database><scores/><additional><submitter>O'Malley G</submitter><funding>NCATS NIH HHS</funding><funding>NIDDK NIH HHS</funding><pagination>807-817</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9057877</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>23(12)</volume><pubmed_abstract>&lt;b>&lt;i>Background:&lt;/i>&lt;/b> Suboptimal glycemic control is associated with maternal and neonatal morbidity and mortality in pregnancy complicated by type 1 diabetes (T1D). Prospective analysis of continuous glucose monitoring (CGM) metrics, insulin pump settings, and insulin delivery can better characterize the changes in glycemic levels and insulin use throughout pregnancy with T1D. &lt;b>&lt;i>Materials and Methods:&lt;/i>&lt;/b> Prescribed parameters, insulin delivery, carbohydrate intake, and CGM data for 25 pregnant women with T1D from three U.S. sites were collected. Participants enrolled before 17 weeks gestation and used personal insulin pumps and study CGM. Mean daily total, basal, and bolus insulin doses (units/kg), CGM time in range (TIR: 63-140 mg/dL), and pump-entered carbohydrates were ana</pubmed_abstract><journal>Diabetes technology &amp; therapeutics</journal><pubmed_title>Longitudinal Observation of Insulin Use and Glucose Sensor Metrics in Pregnant Women with Type 1 Diabetes Using Continuous Glucose Monitors and Insulin Pumps: The LOIS-P Study.</pubmed_title><pmcid>PMC9057877</pmcid><funding_grant_id>UL1 TR002377</funding_grant_id><funding_grant_id>R01 DK120358</funding_grant_id><pubmed_authors>Desjardins D</pubmed_authors><pubmed_authors>McCrady-Spitzer S</pubmed_authors><pubmed_authors>Levy CJ</pubmed_authors><pubmed_authors>Doyle FJ</pubmed_authors><pubmed_authors>Kudva YC</pubmed_authors><pubmed_authors>Rosenn B</pubmed_authors><pubmed_authors>Levister C</pubmed_authors><pubmed_authors>Kremers WK</pubmed_authors><pubmed_authors>Pinsker JE</pubmed_authors><pubmed_authors>Ozaslan B</pubmed_authors><pubmed_authors>Dassau E</pubmed_authors><pubmed_authors>Kaur RJ</pubmed_authors><pubmed_authors>Reid C</pubmed_authors><pubmed_authors>Trinidad MC</pubmed_authors><pubmed_authors>O'Malley G</pubmed_authors><pubmed_authors>Church MM</pubmed_authors><pubmed_authors>Castorino K</pubmed_authors></additional><is_claimable>false</is_claimable><name>Longitudinal Observation of Insulin Use and Glucose Sensor Metrics in Pregnant Women with Type 1 Diabetes Using Continuous Glucose Monitors and Insulin Pumps: The LOIS-P Study.</name><description>&lt;b>&lt;i>Background:&lt;/i>&lt;/b> Suboptimal glycemic control is associated with maternal and neonatal morbidity and mortality in pregnancy complicated by type 1 diabetes (T1D). Prospective analysis of continuous glucose monitoring (CGM) metrics, insulin pump settings, and insulin delivery can better characterize the changes in glycemic levels and insulin use throughout pregnancy with T1D. &lt;b>&lt;i>Materials and Methods:&lt;/i>&lt;/b> Prescribed parameters, insulin delivery, carbohydrate intake, and CGM data for 25 pregnant women with T1D from three U.S. sites were collected. Participants enrolled before 17 weeks gestation and used personal insulin pumps and study CGM. Mean daily total, basal, and bolus insulin doses (units/kg), CGM time in range (TIR: 63-140 mg/dL), and pump-entered carbohydrates were ana</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Dec</publication><modification>2026-07-14T14:28:15.342Z</modification><creation>2025-04-05T09:43:29.808Z</creation></dates><accession>S-EPMC9057877</accession><cross_references><pubmed>34270347</pubmed><doi>10.1089/dia.2021.0112</doi></cross_references></HashMap>